Celldex Therapeutics Competitors and Similar CompaniesClear all
Celldex Therapeutics's competitors and similar companies include Marker Therapeutics and Celling Biosciences.
 Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. | |
Founding Date | Founding Date 1983 | Founding Date 2018 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US | Locations Houston, US HQ | Locations Austin, US HQ Curitiba, BR Dubai, AE |
Employees | Employees 1608% increase | Employees 888% decrease | Employees 47 |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 36.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($258.8m) (FY, 2025) | Net income ($12.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View companyCelling Biosciences
HQ
Austin, US
Employees
47
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View company